.jpeg)
One of our major priorities in next 3-5 years is the introduction of a kit-based version of CanAssist Breast, enabling hospitals conduct the test locally
Suven has already begun planning a global Phase 3 registrational program for MDD based on the results
The newly approved treatment, SKINVIVE by JUVÉDERM, is now the first and only hyaluronic acid injectable cleared specifically for improving neck appearance
Report reveals growing confidence in AI-driven decision-making, but highlights persistent challenges in scaling digital investments and converting innovation into measurable business value
Robotic TAMIS procedure helps 75-year-old patient avoid rectum removal and permanent stoma, enabling faster recovery and preserving quality of life
Since 2022, we have grown threefold and our growth story is built on scale, scientific innovation and deep customer partnerships
Expanded indication makes Stelo the first FDA-cleared OTC CGM for children aged two years and older with diabetes or prediabetes
The study enrolled 639 patients, nearly 80% of whom had previously received a covalent BTK inhibitor
The FDA nod marks a step forward in precision oncology, linking molecular diagnostics more tightly to therapy selection for advanced prostate cancer
The company will unveil preliminary findings showing that Broncho-Vaxom was associated with a 28–38% reduction in respiratory tract infection rates at 12 months
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
